Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs
* Clinical safety and efficacy * Initiation and titration * Administration considerations * Individualizing treatment
Vær den første til at kommentere
Tilmeld dig nu og bliv en del af Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs-fællesskabet!
Derefter 99 kr. / måned · Opsig når som helst.
4 episoder
Clinical Case Vignettes
* Initiating triheptanoin * Dosing modification to improve tolerability
Optimizing Triheptanoin Therapy
Historical Treatment; Introduction of Triheptanoin
* Dietary modification * MCT supplementation * Triheptanoin mechanism of action
Understanding LC-FAODs
* Autosomal recessive inheritance * Carnitine shuttle * Newborn screening * Clinical features
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs-fællesskabet!